Mise à jour le   30/06/2021


"Amplification of the anti-tumour activity of therapeutic antibodies via polysaccharides", Patent No 0505219, deposit 2006.


"Compositions containing antibodies for treating CD5+HLA-DR+B or T cell related diseases", PCT/EP2010/056664, deposit 2010 May 14th.


"Use of digeneaside and its derivatives as an immunostimulating agent", ref: 247510D32793, deposit 2014 June 23rd.


"Method of screening of compounds using membrane STIM1", EP14290232,9, deposit 2014 August 6th.


"Processes for the diagnosis, prognosis and monitoring of the progression of Chronic Lymphoid Leukaemia (CLL) and/or of Systemic Lupus Erythematosus (SLE) using membrane STIM 1", EP15156694,0, deposit 2015 February 26th